Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Harry R Phillips"'
Autor:
Larissa G Rodriguez-Homs MBS, Bradley G Hammill DrPH, Marc D Ryser PhD, Harry R Phillips MD, Paul J Mosca MD, PhD, MBA
Publikováno v:
Journal of Patient Experience, Vol 7 (2020)
Patient experience is an important dimension of health care quality and is assessed using the standard Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey for inpatients. The HCAHPS scores may vary based on survey respons
Externí odkaz:
https://doaj.org/article/94754edeeb77462783d6bf64f3d3a50c
Autor:
Larissa G. Rodriguez-Homs, Sabran J. Masoud, Oliver K. Jawitz, Harry R. Phillips, Paul J. Mosca
Publikováno v:
Abstracts.
Background Improved discharge planning has been implicated in reducing post-operative complications. Readmissions and mortality after coronary artery bypass grafting (CABG) are two procedure-specific complications Medicare publicly reports. While pat
Autor:
Sabran J. Masoud, Cara O'Brien, Larissa G. Rodriguez-Homs, Harry R. Phillips, Paul J. Mosca, Oliver K. Jawitz
Publikováno v:
Abstracts.
Background In 2018, Medicare began public reporting of hospital compliance with Sepsis and Septic Shock Early Management (SEP-1) bundle. We queried whether a relationship between SEP-1 bundle compliance, hospital size, and global measures of quality
Autor:
Andrew Wang, Harry R. Phillips, Sara A. Holleran, Peter K. Smith, G. Chad Hughes, Christopher M. O'Connor, John P. Vavalle, Manesh R. Patel, J. Kevin Harrison
Publikováno v:
The American Journal of Cardiology. 113:1874-1878
Despite advances in the treatment of aortic stenosis (AS), many patients with AS remain untreated. Barriers to accessing cardiovascular surgical care may play a role in this undertreatment. We sought to examine whether there are geographic variations
Autor:
Yan Chun Li, Shu Q. Liu, Harry R. Phillips, Li-Qun Zhang, Di Zhang, Brandon J. Tefft, Derek Roberts, Yu H. Wu, Yupeng Ren, Yong Huang
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 303:H1446-H1458
Myocardial ischemia (MI) activates innate cardioprotective mechanisms, enhancing cardiomyocyte tolerance to ischemia. Here, we report a MI-activated liver-dependent mechanism for myocardial protection. In response to MI in the mouse, hepatocytes exhi
Autor:
Harry R. Phillips, Leslee J. Shaw, Linda K. Shaw, Afshin Farzaneh-Far, Mona Fiuzat, Aijing Z. Starr, Salvador Borges-Neto, Christopher M. O'Connor, Ashwani P. Sastry
Publikováno v:
JACC: Cardiovascular Imaging. 5(7):715-724
ObjectivesThe aim of this study was to evaluate the independent prognostic significance of ischemia change in stable coronary artery disease (CAD).BackgroundRecent randomized trials in stable CAD have suggested that revascularization does not improve
Autor:
Harry R. Phillips, Peter K. Smith, Kerry L. Lee, Eric Yow, Judson B. Williams, Robert H. Jones, Linda K. Shaw, Christopher M. O'Connor, Eric J. Velazquez
Publikováno v:
The Annals of Thoracic Surgery. 93:523-530
Background We prospectively applied the Surgical Treatment of Ischemic Cardiomyopathy trial entry criteria to an observational database to determine whether coronary artery bypass grafting (CABG) decreases mortality compared with medical therapy (MED
Autor:
Steven P. Marso, Ron Waksman, Robert S. Schwartz, Harry R. Phillips, Gregg W. Stone, John A. McPherson, Steven R. Steinhubl, Juan F. Granada, John J. Young
Publikováno v:
Catheterization and Cardiovascular Interventions. 71:367-374
Progressive atherosclerotic disease is responsible for many of the late adverse clinical events that detract from the high procedural and clinical success of percutaneous coronary intervention. Despite recent advances in catheter based technology for
Publikováno v:
Future Cardiology. 2:721-731
In many individuals, the first indicator of atherosclerosis is an acute heart attack, which is often fatal. Despite innovations in medical therapy and interventional cardiology techniques, coronary artery disease continues to be the leading cause of
Autor:
Brigitta C. Brott, Harry R. Phillips, Gregory D. Chapman, Richard S. Stack, William B. Hillegass, Robert M. Califf, James E. Tcheng
Publikováno v:
American Heart Journal. 144:501-507
Background Approximately 50% of percutaneous coronary interventions in the United States are performed with unfractionated heparin and no IIb/IIIa agent. The operator must weigh the risks and benefits of more intensive anticoagulation during these pe